Home
/
Core Laboratories Inc. /DE/
/
Financials
/
Quarterly
Core Laboratories Inc. /DE/ — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Core Laboratories Inc. /DE/ filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$134.52M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$130.16M
Jul 25, 2025
Q1
2025
Mar 31, 2025
$123.59M
Apr 28, 2025
Q3
2025
Sep 30, 2024
$134.40M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$130.58M
Jul 25, 2025
Q1
2025
Mar 31, 2024
$129.64M
Apr 28, 2025
Q3
2024
Sep 30, 2023
$125.34M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$127.88M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$128.36M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$125.97M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$120.90M
Jul 27, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$14.24M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$10.64M
Jul 25, 2025
Q1
2025
Mar 31, 2025
($154.0K)
Apr 28, 2025
Q3
2025
Sep 30, 2024
$11.75M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$9.03M
Jul 25, 2025
Q1
2025
Mar 31, 2024
$3.22M
Apr 28, 2025
Q3
2024
Sep 30, 2023
$9.26M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$22.85M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$2.37M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$7.52M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$7.07M
Jul 27, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$20.93M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$15.29M
Jul 25, 2025
Q1
2025
Mar 31, 2025
$4.42M
Apr 28, 2025
Q3
2025
Sep 30, 2024
$19.80M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$16.01M
Jul 25, 2025
Q1
2025
Mar 31, 2024
$8.57M
Apr 28, 2025
Q3
2024
Sep 30, 2023
$14.67M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$18.91M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$6.48M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$14.65M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$11.65M
Jul 27, 2023